Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Cash & Current Investments (2016 - 2026)

Collegium Pharmaceutical has reported Cash & Current Investments over the past 11 years, most recently at $251.1 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 162.76% year-over-year to $251.1 million; the TTM value through Dec 2025 reached $251.1 million, up 162.76%, while the annual FY2025 figure was $251.1 million, 162.76% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $251.1 million at Collegium Pharmaceutical, down from $285.9 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $325.5 million in Q2 2023 and troughed at $95.6 million in Q4 2024.
  • A 5-year average of $213.7 million and a median of $200.3 million in 2021 define the central range for Cash & Current Investments.
  • Biggest five-year swings in Cash & Current Investments: soared 165.21% in 2023 and later plummeted 69.23% in 2024.
  • Year by year, Cash & Current Investments stood at $186.4 million in 2021, then decreased by 6.83% to $173.7 million in 2022, then surged by 78.8% to $310.5 million in 2023, then plummeted by 69.23% to $95.6 million in 2024, then soared by 162.76% to $251.1 million in 2025.
  • Business Quant data shows Cash & Current Investments for COLL at $251.1 million in Q4 2025, $285.9 million in Q3 2025, and $222.2 million in Q2 2025.